Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis

Osteoporosis International

Volumn 24, Issue 2, 2013, Pages 581-593

  Hopkins, R B ^a,b   Tarride, J E ^a,b,c   Leslie, W D ^d   Metge, C ^d   Lix, L M ^e   Morin, S ^f   Finlayson, G ^d   Azimaee, M ^d   Pullenayegum, E ^a,c,g   Goeree, R ^a,b,c   Adachi, J D ^h   Papaioannou, A ^h   Thabane, L ^a,c,g  

^a MCMASTER UNIVERSITY   (Canada)

^b Programs for Assessment of Technology in Health   (Canada)

^c CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g ST JOSEPH S HEALTH CENTRE   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

Author keywords

Cost of illness; Excess cost; Fracture; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; FRACTURE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; WRIST FRACTURE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; MALE; MANITOBA; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PREVALENCE; SEX FACTORS;

EID: 84873723850     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-1997-7     Document Type: Article

References (28)

1. Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Construction of a FRAX(R) model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 22:817-827
2. Statistics Canada (2010) Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual. Table 051-0001
3. Becker DJ, Kilgore ML, Morrisey MA (2010) The societal burden of osteoporosis. Curr Rheumatol Rep 12:186-191
4. Akobundu E, Ju J, Blatt L, Mullins CD (2006) Cost-of-illness studies: a review of current methods. PharmacoEconomics 24:869-890
5. Strom O, Borgstrom F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, Abdon P, Ornstein E, Ceder L, Thorngren KG, Sernbo I, Jonsson B (2008) Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden. Acta Orthop 79:269-280
6. Leslie WD, Metge CJ, Azimaee M, Lix LM, Finlayson GS, Morin SN, Caetano P (2011) Direct costs of fractures in Canada and trends 1996-2006: a population-based cost-of-illness analysis. J Bone Miner Res 26(10):2419-2429
7. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271-278
8. Melton LJ III, Gabriel SE, Crowson CS, Tosteson AN, Johnell O, Kanis JA (2003) Cost-equivalence of different osteoporotic fractures. Osteoporos Int 14:383-388
9. Orsini LS, Rousculp MD, Long SR, Wang S (2005) Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos Int 16:359-371
10. Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. PharmacoEconomics 28:395-409
11. Rousculp MD, Long SR, Wang S, Schoenfeld MJ, Meadows ES (2007) Economic burden of osteoporosis-related fractures in Medicaid. Value Health 10:144-152
12. Goeree R, O'Reilly D, Hopkins R, Blackhouse G, Tarride JE, Xie F, Lim M (2010) General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals. Expert Rev Pharmacoecon Outcomes Res 10:379-384
13. Knottnerus A, Tugwell P (2008) STROBE - a checklist to strengthen the reporting of observational studies in epidemiology. J Clin Epidemiol 61:323
14. Manitoba Centre for Health Policy (2010) University of Manitoba, Canada
15. WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment (2010) Oslo, 2009
16. Kozyrskyj AL, Mustard CA (1998) Validation of an electronic, population-based prescription database. Ann Pharmacother 32:1152-1157
17. Poss JW, Hirdes JP, Fries BE, McKillop I, Chase M (2008) Validation of Resource Utilization Groups version III for Home Care (RUG-III/HC): evidence from a Canadian home care jurisdiction. Med Care 46:380-387
18. Ontario Ministry of Health and Long Term Care (2010) Long-Term Care Home Financial Policy. Ontario Ministry of Health and Long Term Care
19. Canadian Institute for Health Information (2010) Canadian MIS Database - hospital financial performance indicators, 1999-2000 to 2008-2009
20. Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ (2006) A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol 59:342-353
21. Briggs AH, Claxton K, Sculpher M (2006) Decision modelling for health economic evaluation. Oxford University Press, USA
22. Goeree R, O'Reilly D, Hux J, Lim M, Hopkins R, Tarride J, Blackhouse G, Xie F (2009) Total and excess costs of diabetes and related complications in Ontario. Can J Diabetes 33:35-45
23. Finlayson G, Ekuma O, Yogendran M, Burland E, Forget E (2010) The additional cost of chronic disease in Manitoba. Manitoba Centre for Health Policy, Winnipeg
24. Cochrane Handbook for Systematic Reviews of Interventions (2011) Version 5.1.0
25. StataCorp. Stata Statistical Software: Release 11 (2009)
26. Briggs AH, Mooney CZ, Wonderling DE (1999) Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Stat Med 18:3245-3262
27. Willan AR, O'Brien BJ (1996) Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. Health Econ 5:297-305
28. Thompson SG, Barber JA (2000) How should cost data in pragmatic randomised trials be analysed? BMJ 320:1197-2000